314
Views
35
CrossRef citations to date
0
Altmetric
NEW DRUGS

Evaluation of Gefitinib for Treatment of Refractory Solid Tumors and Central Nervous System Malignancies in Pediatric Patients

, Pharm.D., , M.D., , M.D., , M.D. & , Pharm.D.
Pages 310-317 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jianjian Dai, Daoxin Ma, Shaolei Zang, Dongmei Guo, Xun Qu, Jingjing Ye & Chunyan Ji. (2009) Cross-Talk Between Notch and EGFR Signaling in Human Breast Cancer Cells. Cancer Investigation 27:5, pages 533-540.
Read now
Darren Hargrave. (2009) Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy. British Journal of Neurosurgery 23:4, pages 351-363.
Read now
Darren R Hargrave & Stergios Zacharoulis. (2007) Pediatric CNS tumors: current treatment and future directions. Expert Review of Neurotherapeutics 7:8, pages 1029-1042.
Read now

Articles from other publishers (32)

Clara Alcon, Fernando Martín, Estela Prada, Jaume Mora, Aroa Soriano, Gabriela Guillén, Soledad Gallego, Josep Roma, Josep Samitier, Alberto Villanueva & Joan Montero. (2022) MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment. Cell Death Discovery 8:1.
Crossref
Pouria Rahmanian-Devin, Vafa Baradaran Rahimi, Mahmoud Reza Jaafari, Shiva Golmohammadzadeh, Zahra Sanei-far & Vahid Reza Askari. (2021) Noscapine, an Emerging Medication for Different Diseases: A Mechanistic Review. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-16.
Crossref
Agnieszka Kaczmarska, Patrycja Śliwa, Monika Lejman & Joanna Zawitkowska. (2021) The Use of Inhibitors of Tyrosine Kinase in Paediatric Haemato-Oncology—When and Why?. International Journal of Molecular Sciences 22:21, pages 12089.
Crossref
Monika Lavan, Xueqi Wang, Robyn McCain, Amber Jannasch, Bruce Cooper, Scott Hostetler, Stephen Byrn & Gregory Knipp. (2021) Development of a Pediatric Mini-Tablet Formulation for Expedited Preclinical Studies. AAPS PharmSciTech 22:1.
Crossref
Lu Xie, Jie Xu, Xin Sun, Xiaodong Tang, Taiqiang Yan, Rongli Yang & Wei Guo. (2019) Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial. The Oncologist 24:7, pages e542-e550.
Crossref
Lu Xie, Tao Ji & Wei Guo. (2017) Anti-angiogenesis target therapy for advanced osteosarcoma. Oncology Reports 38:2, pages 625-636.
Crossref
Ming He, Linlin Jiang, Zhaozhou Ren, Guangbin Wang & Jiashi Wang. (2016) Noscapine targets EGFRp-Tyr1068 to suppress the proliferation and invasion of MG63 cells. Scientific Reports 6:1.
Crossref
Federica Saletta, Carol Wadham, David S. Ziegler, Glenn M. Marshall, Michelle Haber, Geoffrey McCowage, Murray D. Norris & Jennifer A. Byrne. (2014) Molecular profiling of childhood cancer: Biomarkers and novel therapies. BBA Clinical 1, pages 59-77.
Crossref
Stefan Rutkowski, Dagmar Hornung, Uwe Kordes, Gertrud Kammler, Christian Hagel, Ulrike Löbel, Martin Ebinger, Jochen Rössler, Anika Resch & Dieter Linhart. 2014. Neuropädiatrie. Neuropädiatrie 277 304 .
Michael Tagen & Clinton F. Stewart. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics 625 659 .
J. K. McCleese, M. D. Bear, S. K. Kulp, C. Mazcko, C. Khanna & C. A. London. (2011) Met interacts with EGFR and Ron in canine osteosarcoma . Veterinary and Comparative Oncology 11:2, pages 124-139.
Crossref
John A HEATH, Stergios ZACHAROULIS & Mark W KIERAN. (2012) Pediatric neuro-oncology: Current status and future directions. Asia-Pacific Journal of Clinical Oncology 8:3, pages 223-231.
Crossref
Gayathri T. Selvarajah, Monique. H. Verheije, Marja Kik, Adri Slob, Peter J.M. Rottier, Jan A. Mol & Jolle Kirpensteijn. (2012) Expression of epidermal growth factor receptor in canine osteosarcoma: Association with clinicopathological parameters and prognosis. The Veterinary Journal 193:2, pages 412-419.
Crossref
Lisa E. S. Crose & Corinne M. Linardic. (2011) Receptor Tyrosine Kinases as Therapeutic Targets in Rhabdomyosarcoma. Sarcoma 2011, pages 1-11.
Crossref
Trevor McKibbin, Wei Zhao, Michael Tagen, Najat C. Daw, Wayne L. Furman, Lisa M. McGregor, J. Russell Geyer, Jeffrey W. Allen & Clinton F. Stewart. (2010) Epidermal growth factor receptor polymorphisms and risk for toxicity in paediatric patients treated with gefitinib. European Journal of Cancer 46:11, pages 2045-2051.
Crossref
G. M. Brodeur. (2010) Getting Into the AKT. JNCI Journal of the National Cancer Institute 102:11, pages 747-749.
Crossref
Jennifer WolterPaola AngeliniMeredith Irwin. (2010) p53 family: therapeutic targets in neuroblastoma . Future Oncology 6:3, pages 429-444.
Crossref
Herbert B. Newton. 2010. Glioblastoma. Glioblastoma 1 42 .
Alberto Donfrancesco, Maria Antonietta De Ioris, Heather Prudence McDowell, Maria Debora De Pasquale, Ilaria Ilari, Alessandro Jenkner, Aurora Castellano, Samantha Cialfi, Clementina De Laurentis & Carlo Dominici. (2010) Gefitinib in combination with oral topotecan and cyclophosphamide in relapsed neuroblastoma: Pharmacological rationale and clinical response. Pediatric Blood & Cancer 54:1, pages 55-61.
Crossref
Tanya M. TrippettCynthia HerzogJames A. WhitlockJohannes WolffJohn KutteschRochelle BagatellStephen P. HungerJessica BoklanAmy A. SmithRobert J. ArceciHoward M. KatzensteinChristopher HarbisonXiaofei ZhouHaolan LuChristiane LangerMartin WeberLia Gore. (2009) Phase I and Pharmacokinetic Study of Cetuximab and Irinotecan in Children With Refractory Solid Tumors: A Study of the Pediatric Oncology Experimental Therapeutic Investigators' Consortium. Journal of Clinical Oncology 27:30, pages 5102-5108.
Crossref
Sabine Mueller & Susan Chang. (2009) Pediatric brain tumors: Current treatment strategies and future therapeutic approaches. Neurotherapeutics 6:3, pages 570-586.
Crossref
Daniela Meco, Tiziana Servidei, Anna Riccardi, Cristiano Ferlini, Gabriella Cusano, Gian Franco Zannoni, Felice Giangaspero & Riccardo Riccardi. (2009) Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo. Neuro-Oncology 11:3, pages 250-259.
Crossref
Nina F. Schor. (2009) New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence. Pharmacology & Therapeutics 122:1, pages 44-55.
Crossref
Bhalchandra A. Diwan, Olga Timofeeva, Jerry M. Rice, Yili Yang, Nirmala Sharma, Mark E. Fortini, Honghe Wang & Alan O. Perantoni. (2009) Inheritance of susceptibility to induction of nephroblastomas in the Noble rat. Differentiation 77:4, pages 424-432.
Crossref
Peter C. Adamson. (2008) Imaging in early phase childhood cancer trials. Pediatric Radiology 39:S1, pages 38-41.
Crossref
Gertrud Kammler, Uwe Kordes, Dagmar Hornung, Dieter Linhart, Christian Hagel & Jochen Rössler. 2009. Neurologische Therapie im Kindesalter. Neurologische Therapie im Kindesalter 215 239 .
Gee-Chen Chang, Chang-Tze Ricky Yu, Ching-Hwa Tsai, Jia-Rong Tsai, Jen-Chi Chen, Chun-Chi Wu, Wen-Jun Wu & Shih-Lan Hsu. (2008) An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells. European Journal of Pharmacology 600:1-3, pages 37-44.
Crossref
Serena S. Freeman, Steven W. Allen, Ramapriya Ganti, Jianrong Wu, Jing Ma, Xiaoping Su, Geoff Neale, Jeffrey S. Dome, Najat C. Daw & Joseph D. Khoury. (2008) Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors . Cancer 113:6, pages 1453-1461.
Crossref
Patrick J. Messerschmitt, Ashley N. Rettew, Robert E. Brookover, Ryan M. Garcia, Patrick J. Getty & Edward M. Greenfield. (2008) Specific Tyrosine Kinase Inhibitors Regulate Human Osteosarcoma Cells In vitro. Clinical Orthopaedics and Related Research 466:9, pages 2168-2175.
Crossref
M Mimeault, R Hauke & SK Batra. (2007) Recent Advances on the Molecular Mechanisms Involved in the Drug Resistance of Cancer Cells and Novel Targeting Therapies. Clinical Pharmacology & Therapeutics 83:5, pages 673-691.
Crossref
Alberto Donfrancesco, Alessandro Jenkner, Maria Antonietta De Ioris, Ilaria Ilari, Aurora Castellano, Clementina De Laurentis, Maria Carmen Garganese, Giuseppe Maria Milano & Carlo Dominici. (2007) Prolonged Response to Oral Gefitinib, Cyclophophamide, and Topotecan in Heavily Pretreated Relapsed Stage 4 Neuroblastoma. Journal of Pediatric Hematology/Oncology 29:11, pages 799-803.
Crossref
Jacques Grill & Ranjeev Bhangoo. (2007) Recent development in chemotherapy of paediatric brain tumours. Current Opinion in Oncology 19:6, pages 612-615.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.